Special Issue "Frontiers in Vaccines for COVID-19 and Related Coronavirus Diseases"
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 34112
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) has been identified as the causative agent of Coronavirus Disease 2019 (COVID-19). The virus was first reported in Wuhan, China, and subsequently rapidly spread around the world, leading to one of the most severe pandemics in human history. By January 2021, more than 94 million confirmed cases have been reported in 191 countries and territories, and more than 2,029 million people have died. Worldwide efforts to stop transmission of SARS-CoV-2 and end the pandemic did not succeed in eradicating the virus, yet. Therefore, the development of effective intervention and prevention strategies is of uttermost importance.
This Special Issue focuses on the following aspects:
1. Development of vaccines against COVID-19 and other coronaviruses
2. Factors influencing vaccine performance and outcome (e.g. environmental, comorbidities, gender).
Dr. Sarah R. Leist
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.